Mireia Margeli Vila

11PUBLICATIONS
101CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsEnvironmental epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 11, 2026
Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies.

Daniel Ortega-Álvarez, David Tébar-García, Marta Casado-Peláez

|Apr 26, 2025
Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort Study.

Helena Pla, Bartomeu Fullana, Anna Esteve

|Jan 25, 2025
Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?

A Navarro-Sabaté, R Font, J A Espinàs

|Jan 17, 2025
Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial.

Maria Vidal, Claudette Falato, Tomás Pascual

|Nov 27, 2024
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Iris Teruel, Eva Castellà, Sabela Recalde

|Jul 25, 2023
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.

Javier Pascual, Miguel Gil-Gil, Paula Proszek

Pageof 2

Frequent Collaborators

5 joint publications

Eudald Felip

4 joint publications

Miguel Gil-Gil

3 joint publications

Montserrat Muñoz-Mateu

3 joint publications

Angelica Ferrando-Díez